Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing

• Published in: BMC immunology 2023-06, Vol.24 (1), p.14-14, Article 14
• Main Authors: Lee, Yi-Yen, Luo, Shao-Ciao, Lee, Chung-Hsin, Tang, Chien-Lun, Shen, Chiung-Chyi, Cheng, Wen-Yu, Yang, Yi-Chin, Yang, Meng-Yin, Yen, Chun-Ming
• Format: Article
• Language: English
• Subjects: Analysis; Antibodies; Antigen (tumor-associated); Antigens; Antitumor activity; Cancer immunotherapy; Cancer therapies; Cancer vaccines; Cell activation; Cell culture; Cell-mediated cytotoxicity; Cloning; Coculture Techniques; Cytokine-Induced Killer Cells; Cytokines; Cytotoxic cell; Cytotoxicity; Dendritic Cells; Dosage and administration; Flow cytometry; Humans; Immunotherapy; Lymphocytes; Manufacturing; Neoplasms; Patient outcomes; Patients; Peripheral blood; Peripheral blood monocyte; Tumor-associated antigen
• ISSN: 1471-2172; 1471-2172
• DOI: 10.1186/s12865-023-00552-5

Dendritic Cell Cytokine-induced killer cell (DC-CIK) coculture treatment in cancer immunotherapy has been shown to be effective. However, the cost of DC- CIK therapy is prohibitive for many patients, and the lack of standard manufacturing processes and treatment strategies are major limitations. Our study used tumor lysate as a tumor-associated antigen source and DCs and CIK cells in coculture. We developed an efficient method to obtain autologous DCs- and CIK cells from peripheral blood. We used flow cytometry to assess DC activation and the cytometric bead array assay to quantify cytokines secreted by CIK cells. We evaluated the antitumor activity of DC- CIK coculture in vitro with the K562 cell line. We demonstrated that a manufacturing process employing frozen immature DCs can yield the lowest loss with the highest economic benefits. DC-CIK coculture can effectively upgrade CIK cells' immunological specificity to tumors in the presence of tumor-associated antigens. In vitro experiments revealed that when the DC- CIK cell ratio was 1: 20 in the coculture, CIK cells secreted the highest number of cytokines on the 14th day and the antitumor immune effect showed the highest potency. CIK cells' cytotoxicity to K562 cells was highest when the CIK: K562 cell ratio was 25: 1. We developed an efficient manufacturing process for DC- CIK coculture, while also establishing the optimal DC- CIK cell ratio for immunological activity and the best cytotoxic CIK: K562 cell ratio.